• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Stroke and Neurointervention in the COVID-19 pandemic: A narrative review
Expert Rev Med Devices. 2021 May 8. doi: 10.1080/17434440.2021.1928495. Online ahead of print.ABSTRACTINTRODUCTION: In this review, we will summarize the impact of the COVID-19 pandemic on neurointerventional care for patients with cerebrovascular disease, with a particular emphasis on epidemiology, neurointerventional processes, and lessons learned from paradigm shifts in endovascular care.AREAS COVERED: Peer-reviewed research is summarized regarding the complications of COVID-19 as related to the pandemic's impact on hospital admissions, imaging capabilities, treatment times, and outcomes of neurointerventional cases.EXP...
Source: Expert Review of Medical Devices - May 10, 2021 Category: Medical Devices Authors: Ameena Rana Thanh N Nguyen James E Siegler Source Type: research

Stroke and neurointervention in the COVID-19 pandemic: a narrative review
Expert Rev Med Devices. 2021 May 17:1-9. doi: 10.1080/17434440.2021.1928495. Online ahead of print.ABSTRACTIntroduction: In this review, we will summarize the impact of the COVID-19 pandemic on neurointerventional care for patients with cerebrovascular disease, with a particular emphasis on epidemiology, neurointerventional processes, and lessons learned from paradigm shifts in endovascular care.Areas covered: Peer-reviewed research is summarized regarding the complications of COVID-19 as related to the pandemic's impact on hospital admissions, imaging capabilities, treatment times, and outcomes of neurointerventional case...
Source: Expert Review of Medical Devices - May 10, 2021 Category: Medical Devices Authors: Ameena Rana Thanh N Nguyen James E Siegler Source Type: research

RapidAI is Set to Acquire EndoVantage for an Undisclosed Sum
M&A is still a thing during the COVID-19 Pandemic. Advanced stroke imaging firm, RapidAI is acquiring EndoVantage, developer of the Find, Track, and Treat comprehensive cerebral aneurysm management platform. Menlo Park, CA-based RapidAI said this acquisition can help it expand its scope, from ischemic stroke to hemorrhagic stroke and now aneurysm. EndoVantage was started at Mayo Clinic and Arizona State University has developed a powerful award-winning computational platform that provides comprehensive cerebral aneurysm management, automating the entire workflow from initial assessment, growth monitoring, to treatment ...
Source: MDDI - June 10, 2020 Category: Medical Devices Tags: Business Cardiovascular Source Type: news